Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-22

Clinical Trial Update: Curcumin Supplementation for the Improvement of Diabetes-related Outcomes [NA]

View source ↗

Summary

A completed Oklahoma State University trial evaluated whether curcumin supplementation can improve diabetes-related outcomes in adults over 60 with prediabetes …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Curcumin (curcumin)

Snippet

Sponsor: Oklahoma State University | Conditions: Over Age 60, Prediabetes or Overweight | NA | Status: COMPLETED